Showing results (431-440 of 500) with videos related to

Sort By:
Pageof 50
Neuro-Oncology|March 19, 2009
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
Neuro-Oncology|November 5, 2025
Reflecting on Scientific Growth and Innovation as the Society for Neuro-Oncology Turns 30Macarena I De La Fuente, Priscilla K Brastianos, Bradley Gampel, et al.
Cancer Cell|September 17, 2015
DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain TumorsTali Mazor, Aleksandr Pankov, Brett E Johnson, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in gliomaTakahide Nejo, Lin Wang, Kevin K Leung, et al.
Acta Neuropathologica|March 1, 2015
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatmentHinke F van Thuijl, Tali Mazor, Brett E Johnson, et al.
Scientific Reports|March 17, 2024
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in gliomaTakahide Nejo, Lin Wang, Kevin K Leung, et al.
The Lancet. Oncology|January 5, 2024
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO groupNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Neuro-Oncology|May 3, 2015
Toward precision medicine in glioblastoma: the promise and the challengesMichael D Prados, Sara A Byron, Nhan L Tran, et al.
Neuro-Oncology Practice|July 19, 2021
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiativeLinda Dirven, Maartje E Vos, Tobias Walbert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2012
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03Eudocia Q Lee, Vinay K Puduvalli, Joel M Reid, et al.
Pageof 50